Earnings Season Beckons But All Anyone Cares About Is Trade War
(Bloomberg) -- One of the biggest casualties of the tariff war has been the power of corporate profits to energize stocks. Now another earnings season is at hand, and not even that can keep investors from obsessing over trade.
It's the story of the market in 2018. U.S. companies are posting the best results in a decade, and the S&P 500 has derived almost no real-time benefit. More frustration played out in the second quarter, when the benchmark climbed a scant 2.9 percent even as profits increased seven times as fast.
“We spent five years in an environment when stock prices moved faster than the earnings growth, a trend that came to a halt,” said Matt Maley, a strategist at Miller Tabak. “You can add to that a really strong headwind that became pronounced in the second quarter: trade. We need guidance to continue to be really good because so many other things aren't.”
You hear it every season: don't worry about about the past, pay attention to the future. In a market whose every effort to right itself has been squelched by a Donald Trump trade tweet, the advice has rarely been more relevant.
Going by the numbers, it will be another huge crop. S&P 500 companies are expected to say income rose 20 percent from a year ago, only slightly less than the January-March period, which saw the fastest growth in seven years. Add the standard beat margin and the final numbers could easily be just as good.
The forecasts are where the drama lies. For months bulls have pinned their hopes on analyst projections that say S&P 500 profits will rise roughly 13 percent a year through 2020. Comments that reinforce those goals have the potential to shake stocks out of their funk. Anything that hurts the outlook could make a weak year worse.
“Companies' forward guidance is going to be more important than it's been in the past,” said Dennis Debusschere, head of portfolio strategy at Evercore ISI. “We have trade, we have a stronger dollar and a general feeling of nervousness around global growth. With earnings, people don't necessarily expect anything extraordinary. With trade, they have no idea.”
The conflict is poised to enter a new phase on Friday when the U.S. is scheduled to slap tariffs on $34 billion of Chinese goods. Beijing has said additional tariffs on some U.S. goods will become effective “immediately” after.
Rising tension over trade and tariffs has already pushed companies from Daimler AG to Osram Licht AG to slash their guidance.
The S&P 500 has spent two months trading sideways as geopolitical tensions rose, a stronger dollar hurt companies' margins and slowing growth in emerging markets undermined the case for a synchronized global recovery.
The irony is, none of that has kept analysts from increasing their earnings estimates for the second quarter -- something they normally don't do this close to reporting season. On average, Wall Street firms have lowered forecasts by around 3 percent in three months heading into the earnings season, according to Bank of America data. It hasn't translated into equity prices.
“Is a deceleration in profit growth a reason to worry? No,” strategists including Savita Subramanian said in a note. “This quarter we will be paying close attention to management guidance and commentary for any deterioration in outlooks driven by uncertainty around growth or trade, which could halt the capex recovery and stall confidence.”
To contact the reporter on this story: Elena Popina in New York at epopina@bloomberg.net
To contact the editors responsible for this story: Courtney Dentch at cdentch1@bloomberg.net, Chris Nagi, Jeremy Herron
©2018 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.